CacheTech Inc. Buys 2,798 Shares of Intuitive Surgical, Inc. $ISRG

CacheTech Inc. grew its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 31.5% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 11,686 shares of the medical equipment provider’s stock after buying an additional 2,798 shares during the period. CacheTech Inc.’s holdings in Intuitive Surgical were worth $4,752,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also made changes to their positions in the company. Fairscale Capital LLC boosted its holdings in Intuitive Surgical by 3.5% in the third quarter. Fairscale Capital LLC now owns 645 shares of the medical equipment provider’s stock valued at $279,000 after acquiring an additional 22 shares during the last quarter. Beaumont Financial Advisors LLC grew its position in Intuitive Surgical by 3.8% during the third quarter. Beaumont Financial Advisors LLC now owns 627 shares of the medical equipment provider’s stock valued at $255,000 after acquiring an additional 23 shares during the period. Hughes Financial Services LLC increased its stake in Intuitive Surgical by 40.7% during the third quarter. Hughes Financial Services LLC now owns 83 shares of the medical equipment provider’s stock worth $37,000 after acquiring an additional 24 shares during the last quarter. Blue Fin Capital Inc. increased its stake in Intuitive Surgical by 0.5% during the first quarter. Blue Fin Capital Inc. now owns 4,794 shares of the medical equipment provider’s stock worth $2,210,000 after acquiring an additional 25 shares during the last quarter. Finally, Red Spruce Capital LLC increased its stake in Intuitive Surgical by 4.1% during the second quarter. Red Spruce Capital LLC now owns 640 shares of the medical equipment provider’s stock worth $255,000 after acquiring an additional 25 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Key Headlines Impacting Intuitive Surgical

These are some of the ISRG headlines that stood out recently:

  • Positive Sentiment: A BTIG Research analyst reportedly expects ISRG shares to rise, providing a positive analyst signal; the headline does not specify a price target or the reasoning. BTIG analyst article
  • Positive Sentiment: Industry coverage casts Intuitive Surgical as a leading beneficiary of expanding surgical-robotics adoption, citing growth in robotic procedures and use of its da Vinci system. A separate medical-device roundup also identifies ISRG as a stock to watch, though neither story reports a new company announcement. Surgical robotics industry article Medical-device stocks article
  • Neutral Sentiment: Options-market coverage notes activity that investors may want to watch, but provides no clear directional conclusion or confirmed catalyst. Options-market article

Wall Street Analysts Forecast Growth

Several equities analysts have recently weighed in on ISRG shares. Robert W. Baird lifted their price objective on Intuitive Surgical from $513.00 to $550.00 and gave the company an “outperform” rating in a research note on Wednesday, October 21st. Wells Fargo & Company reissued an “overweight” rating and set a $486.00 target price (down from $487.00) on shares of Intuitive Surgical in a research report on Wednesday, October 21st. Sanford C. Bernstein reissued an “outperform” rating on shares of Intuitive Surgical in a research report on Wednesday, August 12th. Oppenheimer restated an “outperform” rating and issued a $500.00 price target on shares of Intuitive Surgical in a report on Wednesday, October 21st. Finally, BTIG Research lifted their price target on shares of Intuitive Surgical from $454.00 to $513.00 and gave the company a “buy” rating in a research report on Wednesday. One analyst has rated the stock with a Strong Buy rating, twenty-three have assigned a Buy rating, five have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, Intuitive Surgical has a consensus rating of “Moderate Buy” and an average price target of $495.90.

Get Our Latest Stock Analysis on Intuitive Surgical

Insider Buying and Selling at Intuitive Surgical

In related news, Director Gary Guthart sold 10,000 shares of the business’s stock in a transaction that occurred on Wednesday, November 4th. The stock was sold at an average price of $457.34, for a total transaction of $4,573,400.00. Following the transaction, the director directly owned 1,194,530 shares of the company’s stock, valued at approximately $546,306,350.20. The trade was a 0.83% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Mark Brosius sold 61 shares of the company’s stock in a transaction that occurred on Wednesday, October 28th. The stock was sold at an average price of $441.60, for a total value of $26,937.60. Following the completion of the transaction, the executive vice president owned 581 shares of the company’s stock, valued at approximately $256,569.60. This represents a 9.50% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders sold 39,363 shares of company stock worth $17,738,749. Insiders own 0.60% of the company’s stock.

Intuitive Surgical Price Performance

NASDAQ:ISRG opened at $399.06 on Friday. The business’s 50-day moving average is $423.51 and its two-hundred day moving average is $427.91. Intuitive Surgical, Inc. has a 12 month low of $328.57 and a 12 month high of $603.88. The firm has a market capitalization of $138.33 billion, a PE ratio of 48.25, a price-to-earnings-growth ratio of 2.75 and a beta of 1.45.

Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last issued its earnings results on Tuesday, October 20th. The medical equipment provider reported $3.00 earnings per share for the quarter, topping the consensus estimate of $2.65 by $0.35. Intuitive Surgical had a return on equity of 18.17% and a net margin of 25.54%. The company had revenue of $3.05 billion during the quarter, compared to the consensus estimate of $2.91 billion. During the same quarter in the prior year, the business earned $2.40 earnings per share. The company’s revenue was up 21.7% compared to the same quarter last year. Equities analysts anticipate that Intuitive Surgical, Inc. will post 9.37 EPS for the current year.

Intuitive Surgical Profile

(Free Report)

Intuitive Surgical develops, manufactures and markets robotic-assisted systems for minimally invasive procedures. Its products include da Vinci surgical systems, which allow surgeons to control instruments and a high-definition vision system from a console, as well as the Ion endoluminal system, designed to assist with minimally invasive lung biopsies. The company also provides instruments, accessories, training and support services for its systems. Its technology is used in a range of surgical specialties, including urology, general surgery and gynecology.

Read More

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report).

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.